A Rutgers Health study suggests telehealth could be a viable long-term option for people living with HIV, potentially saving them time, effort and expense related to in-person medical visits.
The study found patients receiving in-person care before the COVID-19 pandemic adapted well to telehealth appointments, maintaining their treatment regimens and health outcomes during the early stages of the crisis.
Researchers interviewed 133 patients living with HIV in Essex County, New Jersey, about their pandemic-era health experiences between October 2020 and June 2021.
The shift to telehealth didn’t appear to hinder patients' HIV treatment, said researchers, adding that 98.5 percent of participants were able to see or speak with an HIV healthcare provider during the pandemic. About 9.4 percent reported having trouble obtaining their antiretroviral therapy (ART) medication after March 4, 2020, when COVID-19 restrictions began in New Jersey.
The study found that 69.2 percent of participants accessed their healthcare providers via telehealth during the pandemic. Of those who used telehealth, 65.3 percent reported being "very happy" or "happy" with how it met their medical care needs, and 92.4 percent rated the overall quality of telehealth care as "excellent," "very good," or "good."
Most patients also maintained their health outcomes. The researchers reported that 65.7 percent of participants had an undetectable viral load, indicating well-managed HIV, and 86.9 percent had a CD4 count of 200 cells per cubic millimeter of blood or higher, suggesting a healthy immune system.
“For those people who were already engaged in care, the pandemic didn't totally disrupt things for them, and they really didn't have a lot of negative health-related outcomes," said Kristen Krause, an assistant professor at the Rutgers School of Public Health and the study's first author.
Concerns arose at the pandemic’s outset about the potential impact on HIV care. Many infectious disease providers were redeployed to focus on COVID-19, raising worries about disruptions to HIV treatment.
However, Krause said those fears proved unfounded for patients already engaged in care.
The researchers also looked for differences in outcomes between older (55 years and above) and younger HIV patients. Contrary to their hypothesis, they found no significant differences between the age groups in adapting to telehealth or maintaining their health outcomes.
"While we hypothesized that older participants may have faced more obstacles and potentially have worse health outcomes due to COVID-19-related care disruptions, we did not see any such differences between those older and younger than 55 years of age," Krause said.
